PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-09-24

Date Title Company
24-Sep-2024 Enalare Receives FDA Clearance to Initiate the First Phase 1 Clinical Study of ENA-001 to Be Conducted in the United States Newswire
24-Sep-2024 Lonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel) Lonza Group AG
24-Sep-2024 Ensysce Biosciences Presenting at Upcoming Meetings AccessWire
24-Sep-2024 Enalare Receives FDA Clearance to Initiate the First Phase 1 Clinical Study of ENA-001 to Be Conducted in the United States AccessWire
24-Sep-2024 Cloud Storage Security Names Kevin Hunt as Chief Technology Officer AccessWire
24-Sep-2024 CBD Life Sciences, Inc. (CBDL) Announces Expanding Revenue Stream With Walmart Marketplace AccessWire
24-Sep-2024 Longwood Healthcare Leaders' Flagship Meeting Boston CEO to Convene Life Science Thought Leaders Across Government, Pharma, Biotech, Academia, and Research Newswire
24-Sep-2024 Interactive Strength Inc. (Nasdaq:TRNR) Successfully Passes EU Compliance for CLMBR and will Start Fulfilling European and UK Orders Immediately AccessWire
24-Sep-2024 Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology AccessWire
24-Sep-2024 Longwood Healthcare Leaders' Flagship Meeting Boston CEO to Convene Life Science Thought Leaders Across Government, Pharma, Biotech, Academia, and Research AccessWire
24-Sep-2024 Alithea Genomics Secures Loan from Swiss Technology Fund Alithea Genomics
24-Sep-2024 ZEO ScientifiX is Moving Toward Its Goal of Transforming Healthcare Through Leading-Edge Research Newswire
24-Sep-2024 Bio-Sourcing secures European Innovation Council (EIC) Accelerator funding to bridge the biomanufacturing gap and make biotherapeutics more available and affordable Andrew Lloyd Associates
24-Sep-2024 Bioz and Boston BioProducts Introduce Advanced Badges and Content Hub to Transform Research Discovery AccessWire
24-Sep-2024 Mabylon AG Receives Research Grants Totaling More Than CHF 1.3 Million for Amyotrophic Lateral Sclerosis (ALS) and Inflammasome Programs Mabylon AG
24-Sep-2024 Marinomed Biotech AG reports positive clinical results for unique Carragelose eye drops Marinomed Biotech AG